Clinical Trials
11 trialsNCT05549037 2026-06-03
LungTIME-C01
Hunan Province Tumor Hospital
Phase 3 Completed
NCT07603661 2026-05-22
Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT03607539 2026-05-11
Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Completed
NCT07309952 2026-04-30
SACTION 2501
Sun Yat-sen University
Phase 2 Recruiting
NCT03872661 2026-04-21
NIBCUN
Sun Yat-sen University
Phase 2 Recruiting
NCT07492342 2026-03-25
K-NADIR
The First Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting
NCT07005336 2026-01-30
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
TJ Biopharma Co., Ltd.
Phase 2 Active not recruiting
NCT07120698 2026-01-05
CTONG 2508
Guangdong Association of Clinical Trials
Phase 2 Recruiting
NCT06512207 2025-09-09
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
Jinzhou Medical University
Phase NA Recruiting
NCT07061535 2025-07-11
STAR-SCLC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
NCT05116462 2025-06-26
Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Active not recruiting